Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Open Access

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation

Marya D Zilberberg*, Smita Kothari and Andrew F Shorr

Critical Care 2009, 13:R94 doi:10.1186/cc7924

Accesses  

  • Last 30 days: 82 accesses
  • Last year: 850 accesses
  • All time: 3064 accesses

Cited by

BioMed Central: 3 citations

Review   Open Access

Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis - review of the literature

G Kofla, M Ruhnke European Journal of Medical Research 2011, 16:159 (28 April 2011)

Abstract | Full text | PDF

Review   Free Highly Accessed

Year in review 2009: Critical Care - infection

Stephan Harbarth, Thomas Haustein Critical Care 2010, 14:240 (5 November 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Commentary   Free

Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?

Yoav Golan Critical Care 2009, 13:180 (21 August 2009)

Abstract | Full text | PDF | PubMed

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations